FDA recommits to prescription drug safety (Miami Herald)
Responding to scathing criticism, the Food and Drug Administration offered a blueprint Tuesday to revamp the way it monitors prescription-drug safety.
Responding to scathing criticism, the Food and Drug Administration offered a blueprint Tuesday to revamp the way it monitors prescription-drug safety.
No comments yet.
You must be logged in to post a comment.
Blog Home